Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

By
Kathryn Wighton
March 12, 2026
3 min

MDSpire News

Objective:

To introduce the TECNIS PureSee intraocular lens approved for cataract surgery.

Approach:

Key Findings:

97% of patients reported no very bothersome visual disturbances post-implantation.
97% of patients would recommend the lens to others.
The lens improves intermediate visual acuity while maintaining distance visual acuity.

Interpretation:

The TECNIS PureSee IOL represents a significant advancement in cataract surgery, offering improved vision capabilities without compromising contrast sensitivity.

Limitations:

The lens will not be available in the US until 2026.
Long-term outcomes and broader population studies are needed to fully assess its effectiveness.

Conclusion:

The TECNIS PureSee IOL is a promising option for cataract patients, particularly those with presbyopia, enhancing visual quality and patient satisfaction.